Decision pending on diabetes medications
Should new medicines to treat type 2 diabetes be funded?
Should more than 50,000 people receive funding for the drugs?
Government drug-funding agency Pharmac is expected to decide next week whether it will fund two new medicines to treat type 2 diabetes.
Botany resident Graham King and thousands of other people who suffer from the condition hope the decision will fall in their favour.
King (pictured) pays $100 a month for Dapagliflozin, which is used to treat the condition.
Despite the cost, he said it helps control his diabetes and has cut the amount of insulin he has to take.
He said he doesn't think people should endure what he has had to to get modern medicines, like Dapagliflozin, Empagliflozin and Dulaglutide, to treat the condition.
"I'm just lucky I can afford $100 a month."
Figures released by the Ministry of Health last year showed there were 45,266 people registered in the Counties Manukau area with type 2 diabetes in 2019.
Pharmac chief executive Sarah Fitt said that next week its board will look at funding both Empagliflozin and Dulaglutide for 50,000 New Zealanders with type two diabetes who have a high risk of complications such as heart and kidney disease.
"Clinical experts told us that there is evidence for significant benefit from these two medicines in people with established or at high risk of cardiovascular and/or renal disease," she said.
🧩😏 Riddle me this, Neighbours…
I am an odd number. Take away a letter and I become even. What number am I?
Do you think you know the answer?
Want to stop seeing these in your newsfeed? No worries! Simply head here and click once on the Following button.
Some Choice News!
DOC is rolling out a new tool to help figure out what to tackle first when it comes to protecting our threatened species and the things putting them at risk.
Why does this matter? As Nikki Macdonald from The Post points out, we’re a country with around 4,400 threatened species. With limited time and funding, conservation has always meant making tough calls about what gets attention first.
For the first time, DOC has put real numbers around what it would take to do everything needed to properly safeguard our unique natural environment. The new BioInvest tool shows the scale of the challenge: 310,177 actions across 28,007 sites.
Now that we can see the full picture, it brings the big question into focus: how much do we, as Kiwis, truly value protecting nature — and what are we prepared to invest to make it happen?
We hope this brings a smile!
Denim, but make it one-of-a-kind 💙
Not every pair of jeans makes it to the rack... but that doesn’t mean their story ends there. Our talented volunteer Annie has been transforming damaged denim into handcrafted bags, hats and aprons in our Onehunga SPCA Op Shop ✂️🧵
This latest batch even features her own hand-sewn designs, and customers have been loving them, they sell almost as soon as they hit the shelf!
It’s creativity, sustainability and community all stitched together, helping animals in need 🐾
📍 217 Onehunga Mall, Onehunga
🕘 9am–5pm, 7 days
Loading…
